Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Fzd2 is important for skin and hair development through various signaling ways.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

Ruxolitinib treatment may cause eyelash growth.

Stress causes hair loss by disrupting hair growth cycles, and combining medical and cosmetic treatments can help manage it.

Pharmacists play a crucial role in safe medication use and interdisciplinary collaboration is key to reducing antimicrobial resistance.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

The guideline provides recommendations for managing alopecia areata effectively.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Combination therapy effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

IL-15 promotes hair growth and protects hair follicles.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.